Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction of Kisqali 600mg Tablet:
Kisqali 600mg Tablet is an anti-cancer medication used in the treatment of metastatic breast cancer. It works by slowing down the growth of cancer cells and eventually eliminating them. This helps alleviate symptoms associated with breast cancer, such as breast lumps, abnormal nipple discharge, or changes in breast appearance.
Kisqali 600mg Tablet can be taken with or without food and is typically used in combination with another medication. The duration of treatment varies depending on your individual needs and response to treatment. It's important to take it at the prescribed dose and duration as recommended by your doctor. Regular blood tests may be required while taking this medication.
Uses of Kisqali 600mg Tablet:
Treatment of metastatic breast cancer
Benefits of Kisqali 600mg Tablet:
Effective in treating metastatic breast cancer
Kisqali 600mg Tablet helps treat breast cancer and can be used alone or in combination with other medications or treatment modalities such as chemotherapy. It is typically prescribed when other medications have not resulted in significant improvement and the cancer has spread to other parts of the body. It relieves symptoms associated with breast cancer, such as breast lumps, abnormal nipple discharge, or changes in breast shape or texture. Kisqali 600mg Tablet inhibits or halts the growth of cancer cells and also prevents their replication. If any side effects bother you, discuss them with your doctor.
Mechanism of action of Kisqali 600mg Tablet:
Kisqali 600mg Tablet is an anti-cancer medication that works by blocking proteins (kinases) that are essential for the growth and division of cells. This slows down the growth of cancer cells and ultimately leads to their elimination.